Cargando…

Gastrointestinal bleeding risk of selective serotonin reuptake inhibitors by level of kidney function: A population‐based cohort study

AIM: To estimate the risk of gastrointestinal (GI) bleeding associated with serotonin reuptake inhibitors (SSRIs) by level of kidney function. METHODS: We conducted a cohort study using the Clinical Practice Research Datalink linked to Hospital Episode Statistics. We identified patients with chronic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iwagami, Masao, Tomlinson, Laurie A., Mansfield, Kathryn E., Douglas, Ian J., Smeeth, Liam, Nitsch, Dorothea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089824/ https://www.ncbi.nlm.nih.gov/pubmed/29864791 http://dx.doi.org/10.1111/bcp.13660

Ejemplares similares

Prevalence, incidence, indication, and choice of antidepressants in patients with and without chronic kidney disease: a matched cohort study in UK Clinical Practice Research Datalink
por: Iwagami, Masao, et al.
Publicado: (2017)

Chronic kidney disease and cause-specific hospitalisation: a matched cohort study using primary and secondary care patient data
por: Iwagami, Masao, et al.
Publicado: (2018)

Severe mental illness and chronic kidney disease: a cross-sectional study in the United Kingdom
por: Iwagami, Masao, et al.
Publicado: (2018)

Diagnosis of acute kidney injury and its association with in-hospital mortality in patients with infective exacerbations of bronchiectasis: cohort study from a UK nationwide database
por: Iwagami, Masao, et al.
Publicado: (2016)

Paediatric acute kidney injury hospital admissions in England 1997–2014: burden and risk factors
por: Henderson, Alasdair, et al.
Publicado: (2019)

Acute kidney injury and infections in patients taking antihypertensive drugs: a self-controlled case series analysis
por: Mansfield, Kathryn E, et al.
Publicado: (2018)

Selective Serotonin Reuptake Inhibitors and Gastrointestinal Bleeding: A Case-Control Study
por: Carvajal, Alfonso, et al.
Publicado: (2011)

Prescription of renin–angiotensin system blockers and risk of acute kidney injury: a population-based cohort study
por: Mansfield, Kathryn E, et al.
Publicado: (2016)

The association between chronic kidney disease and tuberculosis; a comparative cohort study in England
por: Ruzangi, Judith, et al.
Publicado: (2020)

Upper gastrointestinal bleeding in a patient with depression receiving selective serotonin reuptake inhibitor therapy
por: Kumar, Deepak, et al.
Publicado: (2009)

Serotonin reuptake inhibitors and post-gastrostomy bleeding: reevaluating the link
por: Patel, Harish, et al.
Publicado: (2015)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021)

Comparisons of Staphylococcus aureus infection and other outcomes between users of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers: lessons for COVID-19 from a nationwide cohort study
por: Bidulka, Patrick, et al.
Publicado: (2020)

A systematic review comparing the evidence for kidney function outcomes between oral antidiabetic drugs for type 2 diabetes
por: Wilkinson, Samantha V., et al.
Publicado: (2018)

Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study
por: Crellin, Elizabeth, et al.
Publicado: (2018)

Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996)

Selective serotonin reuptake inhibitors and Alzheimer’s disease
por: Mdawar, Bernadette, et al.
Publicado: (2019)

The use of serotonin reuptake inhibitors increases the risk of bleeding in patients with assist devices
por: Auschra, Bianca, et al.
Publicado: (2022)

Pharmacoepidemiology for nephrologists: do proton pump inhibitors cause chronic kidney disease?
por: Tomlinson, Laurie A., et al.
Publicado: (2017)

Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin–angiotensin system blockade: a UK general practice-based cohort study
por: Schmidt, Morten, et al.
Publicado: (2017)

Biochemical monitoring after initiation of aldosterone antagonist therapy in users of renin–angiotensin system blockers: a UK primary care cohort study
por: Sinnott, Sarah-Jo, et al.
Publicado: (2017)

Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study
por: Schmidt, Morten, et al.
Publicado: (2017)

Validity of estimated prevalence of decreased kidney function and renal replacement therapy from primary care electronic health records compared with national survey and registry data in the United Kingdom
por: Iwagami, Masao, et al.
Publicado: (2017)

Selective serotonin reuptake inhibitors increase risk of upper gastrointestinal bleeding when used with NSAIDs: a systemic review and meta-analysis
por: Alam, Syed Mobashshir, et al.
Publicado: (2022)

Serotonin reuptake inhibitors and bleeding risks related to elderly submitted to major orthopedic surgery
por: Savioli, Felicio
Publicado: (2019)

Heart Rate Recovery and Selective Serotonin Reuptake Inhibitors
por: Cerit, Levent
Publicado: (2016)

Selective serotonin reuptake inhibitor-induced galactorrhea with hyperprolactinemia
por: Bhattacharjee, Subir, et al.
Publicado: (2021)

Confounding by Indication in Studies of Selective Serotonin Reuptake Inhibitors
por: Lee, Jimin, et al.
Publicado: (2022)

Long-term effects of bariatric surgery on acute kidney injury: a propensity-matched cohort in the UK Clinical Practice Research Datalink
por: Koppe, Uwe, et al.
Publicado: (2018)

Estrogenic/antiestrogenic activity of selected selective serotonin reuptake inhibitors
por: POP, ANCA, et al.
Publicado: (2015)

Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care
por: Bidulka, Patrick, et al.
Publicado: (2020)

Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram
por: Kumar, Vivek, et al.
Publicado: (2015)

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia
por: Welsch, Patrick, et al.
Publicado: (2018)

Candidate genes for antidepressant response to selective serotonin reuptake inhibitors
por: Lotrich, Francis E, et al.
Publicado: (2005)

Bioimpedance in monitoring of effects of selective serotonin reuptake inhibitor treatment
por: Alexeev, Vasiliy Grigorievich, et al.
Publicado: (2011)

Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?
por: Diav-Citrin, Orna, et al.
Publicado: (2012)

Behavioral destabilization induced by the selective serotonin reuptake inhibitor fluoxetine
por: Kobayashi, Katsunori, et al.
Publicado: (2011)

Enhanced Responsiveness to Selective Serotonin Reuptake Inhibitors during Lactation
por: Jury, Nicholas J., et al.
Publicado: (2015)

Selective Serotonin–norepinephrine Reuptake Inhibitors-induced Takotsubo Cardiomyopathy
por: Vasudev, Rahul, et al.
Publicado: (2016)

Ankle edema after administration of selective serotonin reuptake inhibitors
por: Kontoangelos, Konstantinos, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u8q9uv1lmn4lgh5fksvsqci2bi